Supplemental Tables S1-2.pdf
dataset
posted on 2025-04-09, 10:20 authored by Patryk RemiszewskiPatryk Remiszewski, Piotr Ryszkiewicz, Marta Baranowska-Kuczko, Anna Pędzińska-Betiuk, Krzysztof Mińczuk, Monika Kloza, Jolanta Weresa, Tomasz Hutsch, Barbara MalinowskaInfluence of pulmonary hypertension (PH) and treatment with a combination of ambrisentan (AMB) and tadalafil (TAD) on left ventricular (LV) parameters measured by echocardiography in three weight sets of monocrotaline (MCT)-induced PH rats and their controls (CTR).
Influence of pulmonary hypertension (PH) and treatment with a combination of ambrisentan (AMB) and tadalafil (TAD) on selected physiological parameters in three weight sets of monocrotaline (MCT)-induced PH rats and their controls (CTR).
Funding
New combination therapies for the treatment of pulmonary hypertension aimed at blocking peripheral CB1 cannabinoid receptors plus iNOS inhibition or stimulation of AMPK
National Science Center
Find out more...